U.S. states are spending at a level the nation has not seen in a long time. Yet while it sounds positive, it comes with a few caveats.
The bank's earnings report reveals a new trend for Wall Street, and the continuation of an old theme.
Some of the names on the move ahead of the open.
"JPMorgan Chase continued to perform well in all of our major businesses," says CEO Jamie Dimon.
BlackRock delivered quarterly earnings and revenue that met analysts' expectations on Thursday.
BlackRock's Larry Fink tells CNBC he's worried bond yields will drop further before ultimately going higher.
Bank shares are moving after the first big bank kicks off earnings season.
One key market trend could send stocks even higher, analysts say.
"I don't think we have enough evidence to justify these levels in the equity market at this moment," BlackRock chief Larry Fink tells CNBC.
The Brexit could return to the forefront Thursday, as the Bank of England meets and big U.S. banks start to roll out earnings.
Check out the companies making headlines after the bell Wednesday: Yum Brands, Phillips 66, Monsanto and more.
While many investors have shunned emerging markets over their volatility, the post-Brexit world has made them suddenly much more attractive.
Bank of America Merrill Lynch equity analysts are among the most bearish, and they say the S&P 500 could retest its February lows this summer.
Shares of CSX rose more than 3 percent after the company released its second quarter earnings.
Stock pickers were done in by two major factors: following the crowd and an uneven pattern of correlations among stocks.
SemiLEDs shares nosedived about 18 percent due to weaker-than-expected third quarter results.
Williams Companies shares rose nearly 3 percent in early trading on Wednesday after Goldman Sachs put a "buy" rating on the stock.
Nokia's shares climbed more than 5 percent on Wednesday after it announced an agreement that's likely to boost sales.
First we had FANG, then briefly had STUB, but which acronym will traders use to describe the recent rally in equities?
Shares of embattled firm Valeant Pharmaceuticals fell nearly 5 percent.
Get the best of CNBC in your inbox